Canada: Dissolving A Poison Pill: "When, Not If" Still The Standard In Canadian Take-Over Bids

When HudBay Minerals launched an unsolicited take-over bid for Augusta Resource Corporation, the British Columbia Securities Commission (BCSC) said the Augusta poison pill should go, but only after giving the board of Augusta considerable additional time. Reaffirming the current state of the law in Canada, the BCSC indicated that it is still a matter of "when, not if" a poison pill must go.

On June 27, 2014, the BCSC released the reasons for its decision of May 2, 2014, in which it declined to immediately cease-trade a poison pill implemented by Augusta, but determined that it would cease-trade the pill 74 days later, if, among other things, HudBay's hostile take-over bid for the shares of Augusta remained open for a further 75 days. The reasons were widely anticipated by the legal community for insight into whether the proposals of the Canadian Securities Administrators (CSA) to reform the poison pill regime had influenced the BCSC's decision – as the BCSC had allowed the pill to remain in place for an unusually long period of 156 days. As it turns out, notwithstanding that the BCSC was "mindful of these proposals and the issues raised by them", the BCSC "elected not to follow the changes in policy" reflected in such proposals.

The Facts

Between 2010 and early 2013, HudBay and Augusta engaged in a number of discussions regarding potential transactions between them. During this time, through a combination of open market transactions and private placements with Augusta HudBay acquired 15% of the outstanding common shares of Augusta.

In response to this accumulation of shares, on April 18, 2013, the board of directors of Augusta adopted the pill, with an unusually low triggering threshold of 15%. HudBay was grandfathered under the pill, but any further acquisition of shares by HudBay would trigger the pill. Augusta's shareholders ratified the pill on October 17, 2013.

On February 9, 2014, HudBay announced its bid for Augusta. The bid was conditional on, among other things, a minimum tender condition and the pill being cease-traded, waived or invalidated. The board of Augusta recommended that shareholders reject the bid, noting that a group of shareholders representing 33% of the outstanding shares would not tender to the bid.

HudBay extended the bid twice, resulting in a bid expiry date of May 5, 2014. On April 8, 2014, Augusta made the decision to advance the date of a shareholder meeting called to approve continuation of the pill from May 9, 2014 to May 2, 2014 (i.e., so that shareholder approval of the continuation of the pill could be sought before the bid expired). On April 14, 2014, HudBay applied to the BCSC to have the pill cease-traded. At the meeting held on May 2, 2014, shareholders of Augusta approved the continuation of the pill.

The Decision

On May 2, 2014, the BCSC decided that if HudBay extended the bid to expire no earlier than July 16, 2014, and provided a ten-day extension of the bid if HudBay took up any shares under the bid, the BCSC would issue an order cease-trading the pill on July 15, 2014, unless Augusta issued and filed with the BCSC a news release by July 14, 2014, confirming that it had terminated the pill.

In its analysis, the BCSC considered the principles established in the Icahn Partners LP decision with respect to the public interest in relation to the adoption of poison pills as a defensive take-over bid tactic, specifically that:

  • each shareholder of a target should be allowed to decide whether or not to accept or reject a bid;
  • the board of a target has a fiduciary duty to act in the best interest of the target;
  • pills are not contrary to the public interest when used to buy time for a target to respond appropriately to the bid and they are acceptable only as a temporary defence; and
  • take-over bids are fact-specific so the relevance of the factors will vary with each case.

The BCSC also took the opportunity to reconcile apparently diverging decisions to categorically affirm that poison pills are temporary – it is a question of when, not if, a pill must go. On this basis, the BCSC addressed the question of when the Augusta pill should be cease-traded by referring to the list of non-exhaustive factors set out in the decision of Royal Host Real Estate Investment Trust. Emphasizing that each case is fact-specific, the BCSC focused on the following five factors:

  • the length of time that Augusta had already had to run a process aimed at identifying a superior transaction to the bid;
  • the likelihood of the Augusta board being able to find a superior transaction;
  • whether the bid was coercive, taking into account the waiver of the minimum tender condition;
  • the vote by Augusta shareholders to approve continuation of the pill; and
  • the likelihood that HudBay would extend its bid, if the pill were cease-traded immediately or at a specified date in the future.

The BCSC ultimately concluded that, while there were factors in support of issuing an immediate cease-trade of the pill, such factors were ultimately outweighed by the Augusta shareholder vote in favour of maintaining the pill (the context of which was carefully analyzed by the BCSC and given considerable weight in this circumstance), and the likelihood of extension of the bid by HudBay.


On June 23, 2014, prior to the release of the BCSC's reasons, Augusta and HudBay announced that they had entered into a support agreement in respect of a friendly transaction. The agreement was a result of an increase in consideration by HudBay.

The authors would like to thank Maria Valdivieso for her assistance in preparing this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions